Format

Send to

Choose Destination
J Allergy Clin Immunol Pract. 2017 Nov - Dec;5(6):1551-1555.e1. doi: 10.1016/j.jaip.2017.06.033. Epub 2017 Sep 6.

Evidence Refuting the Existence of Autoimmune/Autoinflammatory Syndrome Induced by Adjuvants (ASIA).

Author information

1
Department of Virology and Immunology, Auckland Hospital, Auckland, New Zealand. Electronic address: rohana@adhb.govt.nz.
2
University of Queensland, Brisbane, Queensland, Australia.
3
Discipline of Paediatrics, School of Medicine, University of Adelaide, Adelaide, South Australia, Australia.
4
Research Centre for Prevention and Health, the Capital Region of Denmark, Copenhagen, Denmark; Department of Clinical Experimental Research, Rigshospitalet, Copenhagen, Denmark; Faculty of Health and Medical Sciences, Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
5
Faculty of Medical and Health Sciences, School of Population Health, University of Auckland, Auckland, New Zealand.

Abstract

Autoimmune/autoinflammatory syndrome induced by adjuvants (ASIA) was described in 2011. Over time the condition and its triggers have broadened to include several autoimmune disorders, the macrophagic myofasciitis syndrome, the Gulf war syndrome, the sick building syndrome, siliconosis, and the chronic fatigue syndrome. The aluminum-containing adjuvants in the hepatitis B vaccine and the human papillomavirus vaccine in particular have been stated to be the major causes of the disorder. Here, we review the specificity of the diagnostic criteria for ASIA. We also examine relevant human data, pertaining to causation, particularly from patients undergoing allergen-specific immunotherapy (IT). Patients undergoing allergen-specific IT receive 100 to 500 times more injected aluminum over 3 to 5 years, compared with hepatitis B and human papillomavirus vaccine recipients. In a large pharmacoepidemiological study, in contrast to case series of ASIA, patients receiving aluminum-containing allergen IT preparations were shown to have a lower incidence of autoimmune disease. In another clinical trial, there were no increases in exacerbations in a cohort of patients with systemic lupus erythematosus immunized with the hepatitis B vaccine. Current data do not support the causation of ASIA by vaccine adjuvants containing aluminum, which should be of reassurance to patients undergoing routine immunizations as well as to those undergoing allergen-specific IT.

KEYWORDS:

ASIA; Autoimmunity; SLE; Vaccines

PMID:
28888842
DOI:
10.1016/j.jaip.2017.06.033
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center